Biological characterization of human immunodeficiency virus type 1 and type 2 mutants in human peripheral blood mononuclear cells (scientific article published on January 1992)

SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat

Q29620254

VPX mutants of HIV-2 are infectious in established cell lines but display a severe defect in peripheral blood lymphocytes

Q33563208

Human immunodeficiency virus type 1 negative factor is a transcriptional silencer

Q33836630

Effects of mutations within the 3' orf open reading frame region of human T-cell lymphotropic virus type III (HTLV-III/LAV) on replication and cytopathogenicity

Q33929164

DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells

Q34048204

The trans-activator gene of HTLV-III is essential for virus replication

Q34161962

A second post-transcriptional trans-activator gene required for HTLV-III replication

Q34162178

Identification of HIV-1 vpr product and function

Q34168026

Functional role of human immunodeficiency virus type 1 vpu.

Q34288200

Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1.

Q34323971

Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor

Q34323995

Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication

Q34603122

Mutational analysis of the human immunodeficiency virus type 2 (HIV-2) genome in relation to HIV-1 and simian immunodeficiency virus SIV (AGM).

Q36800949

In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity

Q36825840

The art gene product of human immunodeficiency virus is required for replication

Q36827056

Viral protein R of human immunodeficiency virus types 1 and 2 is dispensable for replication and cytopathogenicity in lymphoid cells.

Q36829615

Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus

Q37546388

Constitutive expression of human immunodeficiency virus (HIV) nef protein in human astrocytes does not influence basal or induced HIV long terminal repeat activity.

Q40109393

Mutational analysis of the human immunodeficiency virus vpr open reading frame.

Q40116997

Differential effects of nef on HIV replication: implications for viral pathogenesis in the host

Q41757870

Purification and characterization of human immunodeficiency virus type 1 nef gene product expressed by a recombinant baculovirus

Q42071857

A novel gene of HIV-1, vpu, and its 16-kilodalton product

Q42656133

The trans-activator gene of the human T cell lymphotropic virus type III is required for replication

Q44579665

The sor gene of HIV-1 is required for efficient virus transmission in vitro

Q45831189

The HIV 'A' (sor) gene product is essential for virus infectivity

Q45847960

Generation and characterization of the human immunodeficiency virus type 1 mutants

Q45859881

Genomic divergence of HIV-2 from Ghana

Q46381046

P433

issue

1-2

P304

page(s)

157-167

P577

publication date

1992-01-01

P1433

published in

Archives of Virology

Q2860564

P1476

title

Biological characterization of human immunodeficiency virus type 1 and type 2 mutants in human peripheral blood mononuclear cells

P478

volume

123

Reverse relations

cites work (P2860)

Q35842465	Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes
Q50740512	Analysis of HIV-2 Vpx by modeling and insertional mutagenesis.
Q35852056	Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes
Q33806688	Cellular and viral specificities of human immunodeficiency virus type 1 vif protein
Q35868144	Characterization of human immunodeficiency virus type 1 Vif particle incorporation
Q36994727	Characterization of simian immunodeficiency virus SIVSM/human immunodeficiency virus type 2 Vpx function in human myeloid cells
Q35838106	Conservation of an intact human immunodeficiency virus type 1 vif gene in vitro and in vivo
Q36629686	Cysteine residues in the Vif protein of human immunodeficiency virus type 1 are essential for viral infectivity.
Q36654022	Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1
Q40478201	Functional analysis of Vif protein shows less restriction of human immunodeficiency virus type 2 by APOBEC3G.
Q24682903	HIV-1 Vpr interacts with a human 34-kDa mov34 homologue, a cellular factor linked to the G2/M phase transition of the mammalian cell cycle
Q64253074	HUSH, a Link Between Intrinsic Immunity and HIV Latency
Q57178469	Host cell-dependent replication of HIV-1 mutants with deletions in gp41 cytoplasmic tail region is independent of the function of Vif
Q41503378	Human immunodeficiency virus Vpx is required for the early phase of replication in peripheral blood mononuclear cells
Q34465108	Human immunodeficiency virus type 1 Vif is efficiently packaged into virions during productive but not chronic infection
Q33852465	Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA.
Q24685633	Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity
Q34345408	Intravirion processing of the human immunodeficiency virus type 1 Vif protein by the viral protease may be correlated with Vif function.
Q37728096	Limelight on two HIV/SIV accessory proteins in macrophage infection: is Vpx overshadowing Vpr?
Q24684633	Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr
Q21131105	New insights into an X-traordinary viral protein
Q35890940	Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr.
Q36685112	Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes
Q21131138	SAMHD1-Dependent and -Independent Functions of HIV-2/SIV Vpx Protein
Q30417737	SIV replication in human cells
Q40185026	SIVSM/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells
Q73890416	Studies with GFP-Vpr fusion proteins: induction of apoptosis but ablation of cell-cycle arrest despite nuclear membrane or nuclear localization
Q36626506	Subcellular localization of the Vif protein of human immunodeficiency virus type 1.
Q40467634	The Human Immunodeficiency Virus Type 1 vif Gene: The Road from an Accessory to an Essential Role in Human Immunodeficiency Virus Type 1 Replication
Q35851966	The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures.
Q40725617	The genome of feline immunodeficiency virus.
Q40467618	Viral Protein X
Q35866177	vif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus.